Is MDP.TO a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 4.65 CAD. With the latest stock price at 2.70 CAD, the upside of Medexus Pharmaceuticals Inc based on DCF is 68.0%. This means that MDP.TO is a buy according to the DCF valuation model.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.4% | 8.1% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 3.22 - 7.85 | 4.65 |
| Upside | 16.3% - 183.3% | 68.0% |